also tumor protein p53 gene (TP53) and RB1 mutations were found in 91 and 82% of LCNEC tumors, respectively, with RB1 mutations always concurrently with TP53 mutations, and 91% of cases showed absent RB1 protein expression. The gene discussed is TP53; the disease is large cell neuroendocrine carcinoma.